ImmuCell Corporation (ICCC) compared with its closest peers (TKNO, BMRA, IMDX, AMS, OABI): P/E 114.2 vs industry 17.2. Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Alpha Teknova, Biomerica, Insight Molecular Diagnostics, VolitionRx and Q/C Technologies share ImmuCell's sub-industry, diagnostics makers.
| Company | Market Cap | P/E |
|---|---|---|
| Alpha Teknova, Inc. (TKNO) | $398.35M | -11.8 |
| Biomerica, Inc. (BMRA) | $10.05M | -1.4 |
| Insight Molecular Diagnostics Inc. (IMDX) | $131.55M | -4.5 |
| American Shared Hospital Services (AMS) | $9.74M | -9.1 |
| OmniAb, Inc. (OABI) | $731.31M | -3.2 |
| VolitionRx Limited (VNRX) | $3.15M | — |
| Q/C Technologies, Inc. (QCLS) | $15.68M | -0.5 |
| Exagen Inc. (XGN) | $181.92M | -6.6 |
| Personalis, Inc. (PSNL) | $1.79B | -8.8 |
| Biodesix, Inc. (BDSX) | $286.57M | -1.5 |
| Stock P/E | 114.2 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| vs Sector | 428.6% |
| vs Industry | 562.0% |
ICCC overview · ICCC earnings · ICCC financials · ICCC KPIs · ICCC documents · ICCC ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.